People · Operator
Named in public records as an officer, director or promoter · active 2016–2020 · Biotech / Pharma, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| 3Bar Biologics, Inc. | — | Biotech / Pharma | Seed | $2.4M | $26.1M | 2016 |
| Super-H Analytics, Inc. | — | Software / Tech | Pre-Seed | $1.5M | $31.3M | 2017 |
David Bergeron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Bergeron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James - Shields | 1 | 3 |
| Richard Maksimoski | 1 | 1 |
| Bruce Caldwell | 1 | 1 |
| Rashmi Agnihotri | 1 | 1 |
| Kevin Berner | 1 | 1 |
| Suguna Rachakonda | 1 | 1 |
| Nicole Weidner | 1 | 1 |
| Jim Karam | 1 | 1 |
| Stephanie Hughes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.